Production Scanners
PRODUCTS
-
![Antibody drug conjugates ADCs GettyImages-1715913285]( "Antibody-Drug Conjugate")
EirGenix provides client-oriented contract development and manufacturing services for biologics, especially monoclonal antibodies and biosimilars. Combining the capabilities of EirGenix’s strategic partner, Formosa Laboratories, Inc, a high potency API manufacturer, we offer integrated services for Antibody Drug Conjugate (ADC) development and manufacturing.
-
![GettyImages-139602926 labeling, packaging, pharma]( "Packaging Software: OEE, EBR, Track And Trace")
Werum PAS-X Packaging optimizes efficiency, compliance, and transparency in your packaging line, combining OEE monitoring, electronic batch recording, and track & trace in a single scalable system.
-
![mpd4 marki]( "2-18 GHz MMIC 4-Way Wilkinson Power Divider/Power Splitter: MPD4-0218CSP3")
The MPD4-0218CSP3 from Marki Microwave is a compact, chip-scale packaged (CSP3) 2–18 GHz MMIC 4-way power divider/power splitter that delivers exceptional RF performance in a small footprint.
-
![PW-sneak-preview-1-300px-image]( "Think Nano® Positioning | Microscopy | Solutions")
Mad City Labs offers a complete product line of high precision piezo nanopositioners, micropositioners, single molecule microscopes, and atomic force microscopes (AFM).
-
![Let’s Get Checked – Mobile BSL-2+ Clinical Laboratory]( "Mobile BSL-2+ Clinical Laboratory Facility and Equipment from Germfree")
In the aftermath of the COVID-19 pandemic, clinical laboratories were faced with an urgent need to rapidly expand their testing capacity. Given the importance of disease surveillance in a public health crisis, Germfree's priority was to quickly create a series of rapidly deployable laboratory spaces that could be used for disease surveillance in emergencies, as temporary laboratory spaces, and as swing spaces.
WHITE PAPERS AND CASE STUDIES
-
![T-Cells Work to Fight Cancer, Immunotherapy, CAR T-cell therapy-GettyImages-1317697233]( "Revolutionizing Lentiviral Vector Manufacturing For In Vivo, Ex Vivo CAR-T Therapies")
Revolutionizing Lentiviral Vector Manufacturing For In Vivo, Ex Vivo CAR-T TherapiesDiscover how scalable, cost-effective, and high-quality lentiviral vector manufacturing can accelerate both ex vivo and emerging in vivo CAR-T therapies.
-
![Bioreactor-GettyImages-801080522]( "Scale Up Strategy For Oncolytic HSV-1 Vector Manufacturing")
Scale Up Strategy For Oncolytic HSV-1 Vector ManufacturingDiscover how a novel, large-scale production method for herpes simplex virus type-1 vectors has the potential to accelerate the progress of gene therapy and bring it closer to widespread application.
-
![GettyImages-1384528169 oncology study]( "How Community Oncologists View CAR T-Cell Therapy Possibilities And Challenges")
How Community Oncologists View CAR T-Cell Therapy Possibilities And ChallengesLearn how a partner with innovative solutions aimed at overcoming the barriers that limit the real-world impact of CAR T-cell therapy can make these advanced therapies more accessible and affordable.
-
![450x300_Laptop]( "Generate High Quality Data And Execute Full Factorial Design Of Experiments")
Generate High Quality Data And Execute Full Factorial Design Of ExperimentsLearn how a bioprocessing company supplemented their in-house bioreactor capacity and performed large-scale DOE studies using a cloud bioreactor facility.
-
![Industry_Insight_Ideal_CMO]( "Accelerating Cold Chain Expansion: Responding To COVID-19 Challenges")
Accelerating Cold Chain Expansion: Responding To COVID-19 ChallengesReview how leveraging cross-functional teamwork helped complete a cold chain infrastructure expansion in a fraction of the expected timeline, ensuring the production of essential COVID-19 therapeutics.
-
![GettyImages-1180547354 clinical trial tablet research]( "BioIVT Collaborates With IDBS To Deploy IDBS E-WorkBook And Reduce Study Cycle Times")
BioIVT Collaborates With IDBS To Deploy IDBS E-WorkBook And Reduce Study Cycle TimesLearn about a collaboration that has enabled BioIVT to enhance efficiency and responsiveness to its biopharmaceutical clients.
-
![Simplifying The Transition To Multi-Column Chromatography]( "Simplifying The Transition To Multi-Column Chromatography")
Simplifying The Transition To Multi-Column ChromatographyExplore the advantages of multi-column chromatography and how to transfer your process from batch to an intensified system, step-by-step.
-
![Lonza Nucleofector]( "Non-Viral Genetic Modification Using The 4D-Nucleofector LV Unit In CGT")
Non-Viral Genetic Modification Using The 4D-Nucleofector LV Unit In CGTThis paper underscores the 4D-Nucleofector® LV Unit as a pivotal tool for translating genetic modification technologies into scalable, safe, and effective therapeutic solutions.
-
![Resolute® BioSC]( "Simple Orchestration Of Multiple Unit Operations")
Simple Orchestration Of Multiple Unit OperationsGain insight into how consolidating downstream operations into a single automated system can reduce footprint, cut processing time, and minimize manual errors to help teams work more efficiently.
-
![GettyImages-1833005811_support]( "Tackling Product Quality And Safety Issues Through Global Collaboration")
Tackling Product Quality And Safety Issues Through Global CollaborationHow the development and execution of a tiered support system, and its results, positively impacted this global collaboration on capacity, efficiency, and cost management.
-
![Wearable-health-innovation-GettyImages-1347130002]( "Mobile App And Wearable Integration Collects Longitudinal Data")
Mobile App And Wearable Integration Collects Longitudinal DataGet an overview of SISCAPA's utilization of eTechnologies, specifically ePRO, and how their partnership with CDS accurately demonstrates the improvement of data collection and analysis in the biotechnology industry.
-
![Supply Chain Management GettyImages-1304746031]( "Uninterrupted Supply To Meet Demand")
Uninterrupted Supply To Meet DemandExplore a solution for biopharmaceutical companies concerned about the risks an increase in campaign volume can pose to their production timeline.
NEWS
-
ABB And HDF Energy To Develop High-Power Fuel Cell Unit For Large Seagoing Ships12/15/2025
ABB and HDF Energy have signed a joint-development agreement (JDA) to develop a high-power fuel cell unit for marine applications.
-
SoftBank Corp. Develops High-Capacity 6-Cell Capable HAPS Payload, Delivers 5G Connectivity From The Sky In Field Trial9/18/2025
SoftBank Corp. (President & CEO: Junichi Miyakawa, "SoftBank") today announced it newly developed a 6-cell capable communications payload for High Altitude Platform Station (HAPS) stratospheric-based wireless communications that successfully delivered 5G connectivity from the sky to the ground in a field trial.
-
Clariant Teams With Technip Energies To Introduce New Catalyst For Unprecedented Low Steam-To-Oil Ratios In Styrene Production4/9/2025
Clariant, a global leader in specialty chemicals, today announced the launch of StyroMax UL-100, its most advanced ethylbenzene dehydrogenation catalyst to date.
-
Blue Circle Olefins Chooses Rotterdam To Build 100% Circular Olefins Plant11/4/2025
Blue Circle Olefins has selected Rotterdam as the site to develop a commercial Methanol-to-Olefins (MTO) production plant.